Healthequity IncHQY
Price$89.37Intrinsic value$180.38102% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $180.38median of 6 methods · middle span $77-$283based on filings through 31 Jul 2026
Market Price $89.37Price as of 1 Oct 2026
Margin of Safety +101.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 14.2% (near-term consensus, capped) · years 2–5: 14.6%/yr (balance of the path).14.5% per year
Years 6–10: glide to demonstrated growth own history 27.2%, capped at 20%
Per-year rates
Yr 614.6%Yr 714.6%Yr 814.5%Yr 914.5%Yr 1014.5%
14.6% → 14.5%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1113.4%Yr 1212.2%Yr 1311.1%Yr 149.9%Yr 158.8%Yr 167.6%Yr 176.5%Yr 185.3%Yr 194.2%Yr 203.0%
14.5% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)27.2%
Discount rate (cost of equity) 7.1%
Volatility vs market (adjusted beta)0.49

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetHealthequity IncHQYHealth Care
Valuation
P/E32.3×
P/S5.7×
P/B4.0×
EV / Revenue6.2×
EV / EBITDA15.4×
Profitability
Gross margin69.5%
Operating margin24.6%
Net margin17.4%
FCF margin35.8%
Returns
ROE11.9%
ROA7.2%
ROIC8.9%
Growth
Revenue growth (YoY)13.5%
5-yr fwd EPS growth14.5%
Financial strength
Debt / Equity0.47×
Current ratio2.99×
Altman Z-Score4.5
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.